Your browser doesn't support javascript.
loading
Eukaryotic Initiation Factor 5A2 Contributes to the Maintenance of CD133(+) Hepatocellular Carcinoma Cells via the c-Myc/microRNA-29b Axis.
Bai, Hai-Yan; Liao, Yi-Ji; Cai, Mu-Yan; Ma, Ning-Fang; Zhang, Qi; Chen, Jie-Wei; Zhang, Jia-Xing; Wang, Feng-Wei; Wang, Chen-Yuan; Chen, Wen-Hui; Jin, Xiao-Han; Xu, Rui-Hua; Guan, Xin-Yuan; Xie, Dan.
Afiliação
  • Bai HY; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.
  • Liao YJ; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
  • Cai MY; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.
  • Ma NF; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.
  • Zhang Q; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
  • Chen JW; Key Laboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, People's Republic of China.
  • Zhang JX; Guangdong Provincial Key Laboratory of Liver Disease Research, The Third affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.
  • Wang FW; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.
  • Wang CY; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
  • Chen WH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.
  • Jin XH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.
  • Xu RH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.
  • Guan XY; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.
  • Xie D; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.
Stem Cells ; 36(2): 180-191, 2018 02.
Article em En | MEDLINE | ID: mdl-29119708
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Iniciação de Peptídeos / Proteínas Proto-Oncogênicas c-myc / Proteínas de Ligação a RNA / Carcinoma Hepatocelular / MicroRNAs / Antígeno AC133 / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Stem Cells Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Iniciação de Peptídeos / Proteínas Proto-Oncogênicas c-myc / Proteínas de Ligação a RNA / Carcinoma Hepatocelular / MicroRNAs / Antígeno AC133 / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Stem Cells Ano de publicação: 2018 Tipo de documento: Article